Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Pain × cabozantinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 5 Carcinoma, Renal Cell 3 Brain Neoplasms 3 Neoplasm Metastasis 2 Multiple Myeloma 2 Melanoma 2 Kidney Neoplasms 2 Glioma 2 Glioblastoma 2 Carcinoma, Transitional Cell 2 Carcinoma, Non-Small-Cell Lung 2 Astrocytoma 2 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Thyroid cancer, medullary 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Thyroid Cancer, Papillary 1 Thrombocytosis 1 Skin Neoplasms 1 Salivary Gland Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Pain 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Mesothelioma, Malignant 1

Interventions

Morphine 5 Methadone 4 Fentanyl 4 Zoledronic Acid 3 Tapentadol 2 Radiotherapy 2 Pregabalin 2 Prednisone 2 Ketamine 2 Ibandronic Acid 2 Hydromorphone 2 Glutamine 2 Acupuncture Therapy 2 pegfilgrastim 1 oxycodone naloxone combination 1 naloxegol 1 ixabepilone 1 incobotulinumtoxinA 1 imisopasem manganese 1 cyclobenzaprine 1 cabozantinib 1 acetaminophen, aspirin, caffeine drug combination 1 Zolpidem 1 Surveys and Questionnaires 1 Sugars 1 Standard of Care 1 Soybean Proteins 1 Sodium Bicarbonate 1 Ropivacaine 1 Oxycodone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01522443 2018-05-23

COMET-2

Exelixis

Phase 3 Terminated

119 enrolled 21 charts

Pain, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡